CMS names 15 medications for 2028 price negotiation cycle

(By: Paige Twenter for Becker’s Hospital Review)

CMS will negotiate the prices for Trulicity, Biktarvy and 13 other high-cost medications commonly covered by Medicaid Parts B and D, according to a Jan. 27 news release from the agency.

The Medicare Drug Price Negotiation Program enacted its first cycle of negotiated drug prices on Jan. 1, 2026, which included four Type 2 diabetes medications. The 2027 cycle includes 15 medications, with Ozempic, Wegovy and Rybelsus topping the list. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.